🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to determine if the opioid properties of ketamine ...
Status
Completed
Location
Stanford University
Start Date
2016-09
Trial ID
NCT02911597
Treatments Being Tested
The purpose of this study is to understand how ketamine works in the brain ...
Status
Recruiting
Location
Department of Psychiatry & Behavioral Sciences
Start Date
2024-02-24
Trial ID
NCT05940324
Treatments Being Tested
The incidence of opioid use disorders (OUDs) has increased to near-epidemic...
Status
Active Not Recruiting
Location
New York State Psychiatric Institute
Start Date
2017-11-25
Trial ID
NCT03345173
Ideal new treatments for Novel Coronavirus-19 (COVID-19) would help halt th...
Status
Terminated
Location
William Beaumont Hospital
Start Date
2020-04-29
Trial ID
NCT04365985
Treatments Being Tested
The goal of this observational study is to learn about the comparative acut...
Status
Recruiting
Location
Providence Care Hospital
Start Date
2023-03-20
Trial ID
NCT06488586
Treatments Being Tested
The overarching aim of this research is to determine the acute effects of k...
Status
Completed
Location
King's College London
Start Date
2021-09-27
Trial ID
NCT04977674
Treatments Being Tested
To evaluate if naltrexone plus ketamine is effective in reducing depression...
Status
Completed
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT03658330
Treatments Being Tested
The investigators will compare 3 treatment groups (ketamine plus naltrexone...
Status
Completed
Location
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Start Date
2015-01-01
Trial ID
NCT02461927
Treatments Being Tested
Every year, alcohol use disorder (AUD) generates millions of emergency depa...
Status
Completed
Location
Denver Health Medical Center
Start Date
2021-01-19
Trial ID
NCT04562779
Treatments Being Tested